Burning Rock Biotech (BNR) Return on Assets (2020 - 2026)

Burning Rock Biotech's Return on Assets history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q4 2025, with the low at 0.01% in Q4 2022.
• The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
• Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Burning Rock Biotech's Return on Assets stood at 0.01% in 2022, then gained by 3 bps to 0.01% in 2023, then jumped by 41 bps to 0.0% in 2024, then jumped by 82 bps to 0.0% in 2025, then retreated by 9 bps to 0.0% in 2026.
• Business Quant data shows BNR's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.